OOIR: Observatory of International Research

Papers

(The H4-Index of Immunity Inflammation and Disease is 25. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
The relationship between COVID‐19 viral load and disease severity: A systematic review	105
Inflammation initiates a vicious cycle between obesity and nonalcoholic fatty liver disease	66
Does COVID‐19 contribute to development of neurological disease?	60
Adverse events following COVID‐19 mRNA vaccines: A systematic review of cardiovascular complication, thrombosis, and thrombocytopenia	55
Age‐related differences in the immune response could contribute to determine the spectrum of severity of COVID‐19	51
Role of neutrophils in acute viral infection	49
The clinical outcomes of COVID‐19 in HIV‐positive patients: A systematic review of current evidence	44
Ferritin level: A predictor of severity and mortality in hospitalized COVID‐19 patients	43
Efficacy of canakinumab in mild or severe COVID‐19 pneumonia	39
The effect of low serum calcium level on the severity and mortality of Covid patients: A systematic review and meta‐analysis	39
Pterostilbene suppresses oxidative stress and allergic airway inflammation through AMPK/Sirt1 and Nrf2/HO‐1 pathways	37
Current research status of HLA in immune‐related diseases	37
COVID‐19 associated EBV reactivation and effects of ganciclovir treatment	36
Clinical efficacy of fecal microbial transplantation treatment in adults with moderate‐to‐severe atopic dermatitis	36
The complex role of AIM2 in autoimmune diseases and cancers	36
Anti‐inflammatory and immunomodulatory effects of Lactobacillus spp. as a preservative and therapeutic agent for IBD control	33
Polydatin has anti‐inflammatory and antioxidant effects in LPS‐induced macrophages and improves DSS‐induced mice colitis	32
Serum troponin, D‐dimer, and CRP level in severe coronavirus (COVID‐19) patients	30
Follow‐up of renal transplant recipients after acute COVID‐19—A prospective cohort single‐center study	30
Tick salivary gland extract induces alpha‐gal syndrome in alpha‐gal deficient mice	29
RNA m⁶A methylation regulates virus–host interaction and EBNA2 expression during Epstein–Barr virus infection	28
Long‐coronavirus disease among people living with HIV in western India: An observational study	28
A randomized controlled clinical trial on efficacy and safety of anakinra in patients with severe COVID‐19	27
Oral and intranasal vaccines against SARS‐CoV‐2: Current progress, prospects, advantages, and challenges	27
The mitochondrial associated endoplasmic reticulum membranes: A platform for the pathogenesis of inflammation‐mediated metabolic diseases	26

Ferulic acid suppresses interleukin‐1β‐induced degeneration of chondrocytes isolated from patients with osteoarthritis through the SIRT1/AMPK/PGC‐1α signaling pathway	25
Anti‐dsDNA, anti‐nucleosome, anti‐C1q, and anti‐histone antibodies as markers of active lupus nephritis and systemic lupus erythematosus disease activity	25
Cutaneous reactions to COVID‐19 vaccine at the dermatology primary care	25